Development of innovative therapies for hematological malignancies, focusing on immune modulators to enhance outcomes in allogeneic hematopoietic cell transplantation and CAR T cell therapy.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: January 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
Transgene
A
Development of innovative immunotherapies against cancer using advanced genetic engineering and artificial intelligence technologies.
Cellectis
B
Development of cell and gene therapies using gene editing to treat cancer and other diseases. The company uses its TALEN® technology to create off-the-shelf allogeneic CAR T cells.
MaaT Pharma
A
Development of microbiome therapeutics to improve cancer treatment outcomes through immune modulation.
Initiatives identified among leaders
Gouvernance des conditions de travail et sécurité
“MaaT Pharma met en place une gouvernance des condi...” - MaaT PharmaAlignement avec les objectifs de développement durable
“Transgene s'aligne avec les objectifs de développe...” - TransgeneDéveloppement d'une culture inclusive
“Cellectis met en place des actions pour promouvoir...” - Cellectis42% of similar organizations communicate on CSR issues
+826 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports